Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau

Journal of Neuroscience

Volumn 22, Issue 1, 2002, Pages 133-141

  Tanemura, Kentaro ^a   Murayama, Miyuki ^a   Akagi, Takumi ^b   Hashikawa, Tsutomu ^b   Tominaga, Takashi ^c   Ichikawa, Michinori ^c   Yamaguchi, Haruyasu ^c   Takashima, Akihiko ^a  

^a INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^c GUNMA UNIVERSITY   (Japan)

Author keywords

FTDP 17; Neurodegeneration; NFT; Phosphorylated tau; RNA; Tg mouse

Indexed keywords

TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GOLGI COMPLEX; HIPPOCAMPUS; IMMUNOREACTIVITY; MOUSE; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RIBOSOME; TRANSGENIC MOUSE;

EID: 0036138044     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.22-01-00133.2002     Document Type: Article

References (31)

1. Structure, microtubule interactions, and paired helical filament aggregation by tau mutants of frontotemporal dementias
2. The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region
3. Inhibition of tubulin assembly by RNA and other polyanions: Evidence for a required protein
4. Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17
5. Ultrastructural changes in the hippocampal CA1 region following transient cerebral ischemia: Evidence against programmed cell death
6. Missense and silent tau gene mutations cause fronto-temporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements
7. A nucleated assembly mechanism of Alzheimer paired helical filaments
8. Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques
9. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans
10. Tau mutations cause frontotemporal dementias
11. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease
12. Tau filament formation in transgenic mice expressing P301L tau
13. Standardized methyl green-pyronin Y procedures using pure dyes
14. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17
15. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
16. Massive somatodendritic sprouting of cortical neurons in Alzheimer's disease
17. A distinct familial presenile dementia with a novel missense mutation in the tau gene
18. RNA stimulates aggregation of microtubule-associated protein tau into Alzheimer-like paired helical filaments
19. Neurodegenerative tauopathies: Human disease and transgenic mouse models
20. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein
21. Common and distinct tubulin binding sites for microtubule-associated proteins
22. A naphthyl analog of the aminostyryl pyridinium class of potentiometric membrane dyes shows consistent sensitivity in a variety of tissue, cell, and model membrane preparations
23. Characterization of tau phosphorylation in glycogen synthase kinase-3beta and cyclin dependent kinase-5 activator (p23) transfected cells
24. Tau is a candidate gene for chromosome 17 frontotemporal dementia
25. Tau protein pathology in neurodegenerative diseases
26. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia
27. Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau
28. Quantification of optical signals with electrophysiological signals in neural activities of Di-4-ANEPPS stained rat hippocampal slices
29. Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease
30. A neuronal antigen in the brains of Alzheimer patients
31. Fibrillogenesis of tau: Insights from tau missense mutations in FTDP-17